WNT5A and breast carcinoma: Consistent with findings from mammalian development [54], Wnt5a stimulation phosphorylates Vangl2 at critical functional residues across a panel of breast cancer cell lines (Fig. 1e and Additional file 4: Fig. S2f) and loss of VANGL2 suppresses Dvl2 phosphorylation (Fig. 1f).